216 related articles for article (PubMed ID: 10400792)
21. Tree Shrew Cells Transduced with Human CD4 and CCR5 Support Early Steps of HIV-1 Replication, but Viral Infectivity Is Restricted by APOBEC3.
Luo MT; Mu D; Yang X; Luo RH; Zheng HY; Chen M; Guo YQ; Zheng YT
J Virol; 2021 Jul; 95(16):e0002021. PubMed ID: 34076481
[TBL] [Abstract][Full Text] [Related]
22. Human immunodeficiency virus (HIV) envelope binds to CXCR4 independently of CD4, and binding can be enhanced by interaction with soluble CD4 or by HIV envelope deglycosylation.
Bandres JC; Wang QF; O'Leary J; Baleaux F; Amara A; Hoxie JA; Zolla-Pazner S; Gorny MK
J Virol; 1998 Mar; 72(3):2500-4. PubMed ID: 9499113
[TBL] [Abstract][Full Text] [Related]
23. Establishment of an HIV cell-cell fusion assay by using two genetically modified HeLa cell lines and reporter gene.
Sakamoto T; Ushijima H; Okitsu S; Suzuki E; Sakai K; Morikawa S; Müller WE
J Virol Methods; 2003 Dec; 114(2):159-66. PubMed ID: 14625051
[TBL] [Abstract][Full Text] [Related]
24. Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells.
Valenzuela A; Blanco J; Krust B; Franco R; Hovanessian AG
J Virol; 1997 Nov; 71(11):8289-98. PubMed ID: 9343181
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 envelope-dependent restriction of CXCR4-using viruses in child but not adult untransformed CD4+ T-lymphocyte lines.
Mariani SA; Brigida I; Kajaste-Rudnitski A; Ghezzi S; Rocchi A; Plebani A; Vicenzi E; Aiuti A; Poli G
Blood; 2012 Mar; 119(9):2013-23. PubMed ID: 22234680
[TBL] [Abstract][Full Text] [Related]
26. Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation.
Locher CP; Witt SA; Kassel R; Dowell NL; Fujimura S; Levy JA
J Gen Virol; 2005 Apr; 86(Pt 4):1171-1179. PubMed ID: 15784911
[TBL] [Abstract][Full Text] [Related]
27. Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression.
LaBonte JA; Madani N; Sodroski J
J Virol; 2003 Jun; 77(12):6645-59. PubMed ID: 12767984
[TBL] [Abstract][Full Text] [Related]
28. Induction of Tier 1 HIV Neutralizing Antibodies by Envelope Trimers Incorporated into a Replication Competent Vesicular Stomatitis Virus Vector.
Bresk CA; Hofer T; Wilmschen S; Krismer M; Beierfuß A; Effantin G; Weissenhorn W; Hogan MJ; Jordan APO; Gelman RS; Montefiori DC; Liao HX; Schmitz JE; Haynes BF; von Laer D; Kimpel J
Viruses; 2019 Feb; 11(2):. PubMed ID: 30769947
[TBL] [Abstract][Full Text] [Related]
29. Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response.
Quiñones-Kochs MI; Buonocore L; Rose JK
J Virol; 2002 May; 76(9):4199-211. PubMed ID: 11932385
[TBL] [Abstract][Full Text] [Related]
30. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
[TBL] [Abstract][Full Text] [Related]
31. Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus.
Owens RJ; Rose JK
J Virol; 1993 Jan; 67(1):360-5. PubMed ID: 8093220
[TBL] [Abstract][Full Text] [Related]
32. Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage.
Trkola A; Ketas T; Kewalramani VN; Endorf F; Binley JM; Katinger H; Robinson J; Littman DR; Moore JP
J Virol; 1998 Mar; 72(3):1876-85. PubMed ID: 9499039
[TBL] [Abstract][Full Text] [Related]
33. A novel, live-attenuated vesicular stomatitis virus vector displaying conformationally intact, functional HIV-1 envelope trimers that elicits potent cellular and humoral responses in mice.
Rabinovich S; Powell RL; Lindsay RW; Yuan M; Carpov A; Wilson A; Lopez M; Coleman JW; Wagner D; Sharma P; Kemelman M; Wright KJ; Seabrook JP; Arendt H; Martinez J; DeStefano J; Chiuchiolo MJ; Parks CL
PLoS One; 2014; 9(9):e106597. PubMed ID: 25215861
[TBL] [Abstract][Full Text] [Related]
34. Evolution of human immunodeficiency virus type 2 coreceptor usage, autologous neutralization, envelope sequence and glycosylation.
Shi Y; Brandin E; Vincic E; Jansson M; Blaxhult A; Gyllensten K; Moberg L; Broström C; Fenyö EM; Albert J
J Gen Virol; 2005 Dec; 86(Pt 12):3385-3396. PubMed ID: 16298986
[TBL] [Abstract][Full Text] [Related]
35. Evolution of coreceptor use and CD4-independence in envelope clones derived from SIVsm-infected macaques.
Vödrös D; Thorstensson R; Doms RW; Fenyö EM; Reeves JD
Virology; 2003 Nov; 316(1):17-28. PubMed ID: 14599787
[TBL] [Abstract][Full Text] [Related]
36. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
Lee S; Lapham CK; Chen H; King L; Manischewitz J; Romantseva T; Mostowski H; Stantchev TS; Broder CC; Golding H
J Virol; 2000 Jun; 74(11):5016-23. PubMed ID: 10799575
[TBL] [Abstract][Full Text] [Related]
37. Expression and processing of human immunodeficiency virus type 1 gp160 using the vesicular stomatitis virus New Jersey serotype vector system.
Wu K; Kim GN; Kang CY
J Gen Virol; 2009 May; 90(Pt 5):1135-1140. PubMed ID: 19264597
[TBL] [Abstract][Full Text] [Related]
38. T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1alpha contains mutations in the envelope gp120 but does not show a switch in coreceptor use.
Schols D; Esté JA; Cabrera C; De Clercq E
J Virol; 1998 May; 72(5):4032-7. PubMed ID: 9557691
[TBL] [Abstract][Full Text] [Related]
39. A cell line-based neutralization assay for primary human immunodeficiency virus type 1 isolates that use either the CCR5 or the CXCR4 coreceptor.
Trkola A; Matthews J; Gordon C; Ketas T; Moore JP
J Virol; 1999 Nov; 73(11):8966-74. PubMed ID: 10516002
[TBL] [Abstract][Full Text] [Related]
40. Role of V3 independent domains on a dualtropic human immunodeficiency virus type 1 (HIV-1) envelope gp120 in CCR5 coreceptor utilization and viral infectivity.
Foda M; Harada S; Maeda Y
Microbiol Immunol; 2001; 45(7):521-30. PubMed ID: 11529558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
